Is Tempus AI (TEM) The Best AI Healthcare Stock to Buy?

Cathie Wood’s 11 Biggest AI and Data Center Stock Picks. Tempus AI Inc. (NASDAQ:TEM) ranks #5 (see Cathie Wood’s 5 Biggest AI and Data Center Stock Picks).

Tempus AI Inc. (NASDAQ:TEM) is an AI healthcare play in Cathie Wood’s portfolio. It’s a healthcare diagnostics and data platform that builds large-scale patient datasets and applies AI tools to help physicians choose treatments and run clinical decision-making.

Tempus AI Inc’s (NASDAQ:TEM) core moat comes from the scale and depth of its data. It has accumulated more than 450 petabytes of clinical and genomic data. This improves the accuracy and usefulness of its AI models and makes it harder for competitors to replicate its dataset.

Tempus AI Inc. (NASDAQ:TEM) is beginning to expand into related diagnostic markets, which could significantly expand its revenue base. Management estimates that scaling ECG-based testing alone could generate over $200 million in annual revenue over time.

While we acknowledge the potential of TEM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey on Google News.